Friday, December 15, 2017

Others

Home Others

Nutra Pharma Corp (OTCQB:NPHC) – Cutting Edge Pain Management

Summary of Our Research Findings We begin coverage of Nutra Pharma, Corp. with a Buy recommendation and a price target of $0.10 per share. ...

Summary of Our Research Findings SUMMARY - We like the unique “out of the box” marketing plan being put forth by the AFOM management...

Analysis of American CryoStem Corporation (OTC:CRYO)

Summary of Our Research Findings This report offers an analysis of American CryoStem Corporation. We believe there is a positive risk/reward ratio to these...

RepliCel Life Sciences, Inc. – On Verge of Biotech Breakthrough (OTCQB:...

Summary of Our Research Findings We begin coverage of RepliCel Life Sciences, Inc. with an investment opportunities score of “Significant”, based on our belief...

Most Popular